Severity
Moderate
FDA Devices recall · Reported July 10, 2019
Potential for reporting low assay results
Phadia Ab recalled EliA RF IgM Well, REF 14-5600-01 Product Usage: Usage: EliA RF IgM is intended for t… - a moderate-severity action.
EliA RF IgM Well, REF 14-5600-01 Product Usage: Usage: EliA RF IgM is intended for t… was recalled by Phadia Ab in July 10, 2019. Reason: Potential for reporting low assay results. Check the official notice for the remedy. Verify recall #Z-1907-2019 with the FDA Devices before acting.
The recall
Phadia Ab issued this moderate-severity FDA Devices recall-Potential for reporting low assay results.
Sourced from official FDA Devices enforcement records. Verify recall #Z-1907-2019 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1907-2019) was formally reported on July 10, 2019, with the manufacturer initiating the action on May 10, 2019. It is classified under Moderate severity (Class II), with a current status of Terminated. Phadia Ab is listed as the recalling firm, operating out of Uppsala, N/A. Federal records list the affected scope as 30 kits.
The documented reason for this recall is: Potential for reporting low assay results Distribution data in the federal record shows the product reached: US Nationwide n the states of NJ, NY, MI, WV, TX including PR. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
30 kits
Related Recalls
6
3 from same agency
EliA RF IgM Well, REF 14-5600-01 Product Usage: Usage: EliA RF IgM is intended for the in vitro quantitative measurement of IgM class rheumatoid factor antibodies in human serum and plasma (Li-heparin and EDTA) to aid in the diagnosis of rheumatoid arthritis in conjunction with other laboratory and clinical findings. EliA RF IgM uses the EliA IgM method on the instrument Phadia 100, Phadia 250, Phadia 2500 and Phadia 5000.
Potential for reporting low assay results
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-1907-2019 |
| Date reported | July 10, 2019 |
| Date initiated | May 10, 2019 |
| Recalling firm | Phadia Ab |
| Firm location | Uppsala, N/A |
| Affected scope | 30 kits |
| Distribution | US Nationwide n the states of NJ, NY, MI, WV, TX including PR |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported July 10, 2019. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.